NCT00244361View on ClinicalTrials.gov

Effectiveness of Rituximab in Pediatric OMS Patients.

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

25

Participants

Timeline

Start Date

June 30, 2005

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions

Opsoclonus-myoclonus SyndromeOpsoclonusMyoclonusAtaxia

Interventions

DRUG

rituximab

Trial Locations (1)

62794

National Pediatric Myoclonus Center, Department of Neurology, SIU School of Medicine, 751 N Rutledge St, Springfield

Sponsors

Collaborators (1)

Genentech, Inc.

All Listed Sponsors

collaborator

Genentech, Inc.

INDUSTRY

lead

National Pediatric Neuroinflammation Organization, Inc.

OTHER

NCT00244361 - Effectiveness of Rituximab in Pediatric OMS Patients. | Biotech Hunter | Biotech Hunter